case_images: PMC10629860_01
case_images: Location of suspected primary tumour by computed tomography imaging. The patient's colorectal primary tumour, arising in the cecum (red arrow), a pouch connected to the junction of the small and large intestines, appeared as small bowel obstruction (black area in red circle) measuring 5.17 cm in length (green arrows). Pathology of the resected tissue confirmed a G1 low-grade adenocarcinoma with adhesion to the abdominal wall and soft tissue and involvement of two out of 20 lymph nodes. The T4bN1 tumour was removed by right hemicolectomy.
case_images: cro-2023-0016-0001-534628_F01.jpg
case_images: PMC10629860_01_cro-2023-0016-0001-534628_F01.jpg
case_images: F1
case_images: A computed tomographic scan showed a thickened distant terminal ileum and small bowel obstruction (Fig. 1). EMF uses low-energy waves in the radio frequency spectrum up to 5 MHz, and frequencies were chosen from the Spooky-2 database to target colon cancer, liver cancer, and digestive system cancer (www.spooky2.com) (Fig. 3 and online supplementary Table S1).
case_images: MRI images of the liver before and after treatment. Left panel (before treatment): MRI images of the patient's liver on March 21, 2022. Five lesions were detected before treatment, including the main lesion 1, 12 mm in size (red arrow) and 4 smaller lesions 2-5 (white arrows). Right panel (after treatment): MRI images on July 22, 2022. Lesion 1 reduced in size 9 mm (red arrow) and previous 4 smaller lesions were no longer visible. A, anterior (front of patient); P, posterior (back of patient); R, right side of patient; L, left side of patient.
case_images: cro-2023-0016-0001-534628_F02.jpg
case_images: PMC10629860_01_cro-2023-0016-0001-534628_F02.jpg
case_images: F2
case_images: The diagnosis was updated to metastatic colon cancer T4bN1 stage-IV (February 23, 2022) (Fig. 2 left, panel/before treatment). Figure 2 illustrates comparative MRI scans of the liver at time of diagnosis before and after treatment. Furthermore, a positron emission tomography scan provided no evidence of metabolically active disease recurrence or metastasis.
case_images: EMF-Rife frequency device "Spooky-2" with plasma bulb held by the patient during treatment. Frequency range: 0-5 MHz (MHz = 106 Hz); device specifications at www.spooky2.com.
case_images: cro-2023-0016-0001-534628_F03.jpg
case_images: PMC10629860_01_cro-2023-0016-0001-534628_F03.jpg
case_images: F3
case_images: EMF uses low-energy waves in the radio frequency spectrum up to 5 MHz, and frequencies were chosen from the Spooky-2 database to target colon cancer, liver cancer, and digestive system cancer (www.spooky2.com) (Fig. 3 and online supplementary Table S1).